-
Tris Pharma, Athena Bioscience Enter Exclusive License Agreement
contractpharma
February 23, 2021
Athena gains exclusive rights to commercialize a long-acting antihypertensive product developed using Tris' proprietary technology.
-
Partnership between the BP and USP to be formalised
europeanpharmaceuticalreview
September 24, 2019
The British Pharmacopoeia and United States Pharmacopeia partnership is to be formalised to strengthen the quality of medicines and public health.
-
Prevalence of Apnea High in Individuals With Resistant HTN
drugs
September 16, 2019
Individuals with resistant hypertension (RH) have a high prevalence of obstructive sleep apnea (OSA), with a dose-response association observed between the severity of OSA and blood pressure (BP) values...
-
Lower Systolic BP Goal May Cut Risk for Orthostatic Hypotension
drugs
September 10, 2019
In adults with recent stroke, a lower systolic blood pressure (SBP) goal may reduce the risk for orthostatic hypotension (OH) without any effect on orthostatic symptoms...
-
Intensifying BP Meds at Hospital Discharge May Harm Elderly
drugs
August 23, 2019
Increasing blood pressure medications at hospital discharge for elderly patients hospitalized with noncardiac conditions does not improve long-term outcomes and is tied to short-term harms...
-
High, Increasing BP in Midlife Tied to Brain Changes in Late Life
drugs
August 22, 2019
There appears to be a correlation for high and increasing blood pressure (BP) from early adulthood and into midlife with white matter hyperintensity volume (WMHV) and smaller brain volumes at age 69 to 71 years...
-
Intensive BP Therapy Not Beneficial in Nursing Home Residents
drugs
August 19, 2019
Long-term nursing home residents with hypertension do not experience significant benefits from more intensive antihypertensive treatment, according to...
-
Nonpersistence, Low Adherence to BP Meds Common in Under 65s
drugs
August 16, 2019
Nonpersistence and low adherence are common among younger adults initiating antihypertensive medications and have not improved over time...
-
Authors Say Lower BP Targets May Cut Recurrent Stroke Risk
drugs
July 30, 2019
Intensive blood pressure (BP) lowering nonsignificantly reduces the risk for recurrence among patients with a history of stroke compared with a standard BP-lowering regimen...
-
A Comparison of Update Cycle and Characteristics of Pharmacopeia of each country (2)
muzhang
March 19, 2018
Update Cycle and Characteristics of Pharmacopeia of USP, BP and EP